Compare BHB & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHB | PACB |
|---|---|---|
| Founded | 1887 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 632.2M | 521.8M |
| IPO Year | 1995 | 2010 |
| Metric | BHB | PACB |
|---|---|---|
| Price | $39.23 | $1.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $37.00 | $1.67 |
| AVG Volume (30 Days) | 125.8K | ★ 6.6M |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.95% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.81 | N/A |
| Revenue | N/A | ★ $93,468,000.00 |
| Revenue This Year | $22.68 | $11.32 |
| Revenue Next Year | $3.66 | $12.14 |
| P/E Ratio | $47.19 | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $28.06 | $1.09 |
| 52 Week High | $39.67 | $2.73 |
| Indicator | BHB | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 63.93 | 40.79 |
| Support Level | $33.85 | $1.27 |
| Resistance Level | $39.48 | $1.79 |
| Average True Range (ATR) | 0.98 | 0.09 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 89.91 | 5.56 |
Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements, and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, fiduciary services, investment planning, education funding, and individual retirement planning.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.